Evidence map›Paper›PMID 41219349›Full record

ArticleScientific reports2025

Idiopathic hyposmia as a marker of prodromal Parkinson's disease - a cohort study.

Zara Markovic-Obiago, Jonathan P Bestwick, Harneek Chohan, Anette Schrag, Cristina Simonet, Alastair J Noyce

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zara Markovic-ObiagoCentre for Preventive Neurology, Queen Mary University of London, London, UK. zara.markovic-obiago@nhs.net.ORCID http://orcid.org/0009-0008-5830-4185
Jonathan P BestwickCentre for Preventive Neurology, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-3088-8616
Harneek ChohanCentre for Preventive Neurology, Queen Mary University of London, London, UK.ORCID https://orcid.org/0000-0003-0561-758X
Anette SchragDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID http://orcid.org/0000-0002-9872-6680
Cristina SimonetCentre for Preventive Neurology, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-5555-0283
Alastair J NoyceCentre for Preventive Neurology, Queen Mary University of London, London, UK. a.noyce@qmul.ac.uk.ORCID http://orcid.org/0000-0003-3027-5497

Funding

Parkinson's UK G2102
6 · The paper itself

Abstract

Olfactory dysfunction is a well-established prodromal symptom of Parkinson's disease (PD) and may occur years prior to PD diagnosis. This study assessed validity of a shortened 5-item smell test in a large cohort of PREDICT-PD participants and investigated its associations with previously described prodromal and demographic factors. Participants without PD aged over 60 years-old completed a 5-item smell test and online platform including validated questionnaires - such as the REM Sleep Behaviour Disorder Single-Question Screen (RBD1Q) and Unified Parkinson's Disease Rating Scale (UPDRS) - as well as subjective olfaction assessment, and motor function assessment via the BRadykinesia Akinesia INcoordination (BRAIN) tap test. Log odds for PD were derived from smell test performance. Data was analysed by non-parametric tests in R-studio. A total of 1472 participants were included. Smell test performance declined with age and was poorer in males. Log odds for PD derived from the smell test correlated with RBD screening and bradykinesia as measured by BRAIN tap test but not motor impairment subjectively assessed by UPDRS part 2. Subjective olfactory assessments correlated weakly with objective smell test performance, with only fair agreement. Notably, subjective smell ratings did not correlate with motor function, whereas objective smell test results did. This study supports the feasibility of a shortened olfactory test for PD risk stratification in prodromal populations. Some previously described associations with prodromal and demographic factors were reaffirmed. Findings highlight the association between early motor dysfunction and olfactory impairment, emphasising the need for objective olfactory testing in research and clinical practice.

Indexed as

AnosmiaOlfaction DisordersParkinson DiseaseProdromal SymptomsAgedBiomarkersCohort StudiesFemaleHumansMaleMiddle AgedREM Sleep Behavior DisorderSmellSurveys and QuestionnairesBiomarkersHyposmiaOlfactionParkinson’s diseaseProdrome

Identifiers

PMID41219349
PMCPMC12606346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.